Man Group plc bought a new stake in Nature’s Sunshine Products, Inc. (NASDAQ:NATR – Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 126,873 shares of the company’s stock, valued at approximately $2,766,000.
A number of other institutional investors have also recently made changes to their positions in NATR. Hsbc Holdings PLC bought a new position in shares of Nature’s Sunshine Products during the 2nd quarter worth $271,000. Canada Pension Plan Investment Board purchased a new stake in Nature’s Sunshine Products during the second quarter valued at about $338,000. Legal & General Group Plc purchased a new stake in Nature’s Sunshine Products during the second quarter valued at about $30,000. Algert Global LLC boosted its position in Nature’s Sunshine Products by 24.3% during the second quarter. Algert Global LLC now owns 123,895 shares of the company’s stock worth $2,701,000 after purchasing an additional 24,182 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. bought a new position in Nature’s Sunshine Products during the second quarter worth about $2,366,000. Hedge funds and other institutional investors own 79.40% of the company’s stock.
Nature’s Sunshine Products Trading Down 0.4%
Nature’s Sunshine Products stock opened at $14.15 on Tuesday. The firm’s 50 day simple moving average is $18.86 and its 200 day simple moving average is $22.32. The firm has a market capitalization of $249.04 million, a PE ratio of 14.01 and a beta of 0.88. Nature’s Sunshine Products, Inc. has a 1-year low of $12.97 and a 1-year high of $28.14.
Wall Street Analysts Forecast Growth
Several analysts have recently issued reports on the stock. Weiss Ratings lowered shares of Nature’s Sunshine Products from a “hold (c+)” rating to a “hold (c)” rating in a research report on Tuesday, August 18th. DA Davidson cut their price objective on shares of Nature’s Sunshine Products from $33.00 to $25.00 and set a “buy” rating for the company in a report on Monday, August 10th. Canaccord Genuity Group reduced their price objective on shares of Nature’s Sunshine Products from $37.00 to $36.00 and set a “buy” rating for the company in a research note on Thursday, July 30th. Finally, Wall Street Zen cut shares of Nature’s Sunshine Products from a “buy” rating to a “hold” rating in a report on Sunday, August 16th. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $30.50.
Read Our Latest Research Report on Nature’s Sunshine Products
Insider Buying and Selling
In related news, EVP Kevin R. Herbert sold 2,000 shares of Nature’s Sunshine Products stock in a transaction on Friday, June 12th. The stock was sold at an average price of $20.68, for a total transaction of $41,360.00. Following the completion of the sale, the executive vice president owned 48,866 shares of the company’s stock, valued at approximately $1,010,548.88. This trade represents a 3.93% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder Prescott Group Capital Managem bought 20,000 shares of Nature’s Sunshine Products stock in a transaction that occurred on Monday, August 17th. The shares were acquired at an average price of $14.69 per share, with a total value of $293,800.00. Following the completion of the transaction, the insider owned 1,944,486 shares of the company’s stock, valued at $28,564,499.34. This represents a 1.04% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last quarter, insiders have acquired 161,389 shares of company stock worth $2,612,536. Corporate insiders own 3.10% of the company’s stock.
Nature’s Sunshine Products Company Profile
Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.
The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.
See Also
- Five stocks we like better than Nature’s Sunshine Products
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Want to see what other hedge funds are holding NATR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nature’s Sunshine Products, Inc. (NASDAQ:NATR – Free Report).
Receive News & Ratings for Nature's Sunshine Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nature's Sunshine Products and related companies with MarketBeat.com's FREE daily email newsletter.
